帕金森病的冷漠度得分与激励运动任务中的EEG组件有关
Soojin Lee1, Esther Song1,2, Maria Zhu1,3
1Pacific Parkinson's Research Centre, The University of British Columbia, Vancouver, BC V6T 2B5, Canada.
Brain communications
|February 19, 2024
概括
改变的大脑波活动,特别是低β和theta振荡,与帕金森病 (PD) 患者在奖励处理和运动任务期间的冷漠有关. 这些发现表明神经调节疗法的潜在目标.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 生物医学工程 生物医学工程
背景情况:
- 漠不关心是帕金森病 (PD) 的常见非运动症状,显著影响生活质量.
- 基本的神经生理学机制的冷漠在PD仍然不太了解,阻碍了有针对性的干预措施的发展.
- 了解这些机制对于推进PD无情的神经调节策略至关重要.
研究的目的:
- 为了研究与帕金森病患者的冷漠相关的神经振荡特征.
- 为了探索大脑活动,冷漠程度和运动任务期间的奖励处理之间的关系.
- 为了确定潜在的基于EEG的生物标志物和PD相关的冷漠的神经调节目标.
主要方法:
- 使用脑电图 (EEG) 来记录在帕金森病患者有或没有冷漠的激励运动任务期间的大脑活动,以及健康的对照.
- 采用多组法定相关性分析来分析事件相关的光谱扰动,以响应奖励线索和运动执行.
- 与临床冷漠度得分和认知评估相关的神经振荡模式 (蒙特利尔认知评估).
主要成果:
- 与对照组相比,帕金森病无动于衷的患者在奖励暗示呈现期间,在表层区域的低β (12-20 Hz) 功率抑制 (脱同步) 减少.
- 这种β脱同步与临床冷漠症严重程度有显著的相关性,与传统分析不同.
- 在无动于衷的PD患者中,在奖励提示和运动任务中观察到过度的theta (4-8Hz) 功率,与认知得分相关. 在无动于心的群体中,比中部地区更低的β功率被发现.
结论:
- 改变的低β和θ振荡是帕金森病中冷漠的关键神经相关物,特别是在奖励处理和运动规划过程中.
- 这些特定的振荡模式可以作为PD无动于衷的生物标志物.
- 这些发现突出了非侵入性神经调节干预措施的潜在目标,旨在缓解帕金森病中的冷漠.
更多相关视频
10:28Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
15.2K
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
7.8K
相关概念视频
01:37Neural Regulation
34.8K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
34.8K
01:15Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
01:24Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
01:24Parkinson Disease l: Introduction
28
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
28
01:24Parkinson Disease ll: Pathophysiology
34
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
34